Indoco Remedies Board of Directors

Get the latest insights into the leadership at Indoco Remedies. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Suresh G KareChairman
Aditi PanandikarManaging Director
Sundeep V BambolkarJoint Managing Director
Vasudha V KamatNon Executive Independent Director
Abhijit Y GoreNon Executive Independent Director
Ajay MulgaokarNon Executive Independent Director
Satish ShenoyNon Executive Independent Director
Anand NadkarniNon Executive Director
Ramanathan HariharanCompany Secretary & Compliance Officer, Head - Legal

Indoco Remedies Share price

INDOCO

214.18

0.98 (0.46%)
NSE
BSE
Last updated on 22 Apr, 2026 | 15:31 IST
Today's High

215.33

Today's Low

212.00

52 Week Low

162.19

52 Week High

349.80

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Indoco Remedies FAQs

The board at Indoco Remedies consists of experienced professionals, including Suresh G Kare, Aditi Panandikar, and others, overseeing the company’s strategic and corporate governance.

Directors at Indoco Remedies are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Suresh G Kare is the current chairman at Indoco Remedies.

Executive directors at Indoco Remedies are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Indoco Remedies adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Indoco Remedies, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost